The complement component C5a induces the expression of plasminogen activator inhibitor-1 in human macrophages via

S P Kastl1, W S Speidl, C Kaun

  • 1Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria.

Insights

Complement component C5a significantly increases plasminogen activator inhibitor-1 (PAI-1) in human macrophages, potentially influencing thrombus formation in atherosclerosis.

Area of Science:

  • Immunology
  • Cardiovascular Biology
  • Molecular Medicine

Background:

  • Atherosclerosis is a chronic inflammatory disease where complement activation plays a key role.
  • Complement components, including C5a, are found in atherosclerotic plaques.
  • Elevated C5a levels correlate with adverse cardiovascular events, suggesting its involvement in disease progression.

Purpose of the Study:

  • To investigate the role of complement components C3a and C5a in regulating plasminogen activator inhibitor-1 (PAI-1) production in human macrophages.
  • To elucidate the signaling pathways involved in C5a-mediated PAI-1 regulation.

Main Methods:

  • Human monocyte-derived macrophages (MDM) and human plaque macrophages were cultured.
  • Macrophages were incubated with complement component C5a.
  • PAI-1 levels were measured using real-time polymerase chain reaction (RT-PCR) and other assays.
  • NF-kappaB activation was assessed using specific inhibitors and DNA binding assays.

Main Results:

  • C5a significantly upregulated PAI-1 expression in both MDM (up to 11-fold) and plaque macrophages (up to 2.7-fold) at both protein and mRNA levels.
  • The C5a-induced PAI-1 increase was mediated through the C5a receptor (C5aR/CD88) and involved NF-kappaB activation.
  • The effects of C5a were independent of TNF-alpha and oxidative burst.

Conclusions:

  • C5a upregulates PAI-1 in macrophages via NF-kappaB activation.
  • This C5a-induced PAI-1 upregulation may promote thrombus development and stabilization within atherosclerotic lesions.
  • Alternatively, C5a-mediated PAI-1 increase in plaque macrophages might serve as a protective mechanism against plaque rupture.
Abstract

Related Concept Videos

Complement System01:27

Complement System

The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a membrane...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Cytoskeletal Linker Proteins - Plakins01:09

Cytoskeletal Linker Proteins - Plakins

Plakins are large proteins with binding domains for microtubules, microfilaments, intermediate filaments, and membrane-associated protein complexes at cell junctions. Plakin functions are evolutionarily conserved and are primarily involved in organizing the different components of the cytoskeleton by crosslinking them to each other and connecting them to the cell-matrix and cell adhesion complexes. They are also known to interact with signal transducers, serve as scaffolds for signaling...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...